Literature DB >> 2399534

Hepatotoxicity of mitoxantrone and doxorubicin.

S F Llesuy1, S L Arnaiz.   

Abstract

Doxorubicin and mitoxantrone were given to mice in a single dose of 15 mg/kg body wt (i.p.) and lipid peroxidation assays were carried out 3, 4 and 5 days after injection. Four days after injection, mitoxantrone induced an increase of 155% in liver spontaneous chemiluminescence and increases of 73% and 52% in malonaldehyde levels and hydroperoxide-initiated chemiluminescence of liver homogenates. Three days after injection, administration of doxorubicin produced increases of 51% and 53% in liver spontaneous chemiluminescence and malonaldehyde formation respectively, but no changes in hydroperoxide-initiated chemiluminescence of liver homogenates were observed. The hepatic levels of antioxidant enzymes were measured in mice treated with doxorubicin or mitoxantrone. Administration of mitoxantrone caused decreases of 50%, 27% and 42% in Cu-Zn superoxide dismutase, catalase and glutathione peroxidase activities, respectively. Doxorubicin also induced decreases in antioxidant enzyme levels but the effect was less marked. Our studies suggest that mitoxantrone might be more hepatotoxic than doxorubicin and that the mechanism of its toxicity would involve a reduction in antioxidant defenses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2399534     DOI: 10.1016/0300-483x(90)90042-f

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  3 in total

1.  Atorvastatin facilitates chemotherapy effects in metastatic triple-negative breast cancer.

Authors:  Juan Luis Gomez Marti; Colin H Beckwitt; Amanda M Clark; Alan Wells
Journal:  Br J Cancer       Date:  2021-08-30       Impact factor: 9.075

2.  Rutin and Quercetin Counter Doxorubicin-Induced Liver Toxicity in Wistar Rats via Their Modulatory Effects on Inflammation, Oxidative Stress, Apoptosis, and Nrf2.

Authors:  Osama M Ahmed; Mohammed H Elkomy; Hanaa I Fahim; Mohamed B Ashour; Ibrahim A Naguib; Badrah S Alghamdi; Heba Uallah R Mahmoud; Noha A Ahmed
Journal:  Oxid Med Cell Longev       Date:  2022-07-27       Impact factor: 7.310

3.  An evaluation of hepatotoxicity in breast cancer patients receiving injection Doxorubicin.

Authors:  G Damodar; T Smitha; S Gopinath; S Vijayakumar; Ya Rao
Journal:  Ann Med Health Sci Res       Date:  2014-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.